The Querrey InQbation Lab hosts resident teams that include some of Northwestern’s brightest minds and innovative technologies. Resident startups at the The InQbation Lab can take advantage of several key entrepreneurial resources: mentorship, legal assistance, discounts, funding, work spaces, libraries, and more. Learn more about our resident resources.
HIDENN-AI is developing convolution hierarchical deep-learning neural networks to simultaneously train, solve, and calibrate any advanced materials and manufacturing system, reducing solution time and data storage by orders of magnitude.
Wing Kam Liu, Professor of Mechanical Engineering, McCormick School of Engineering
ImmPro has developed a mass spectrometry platform, available as contract research services, that directly measures biologically significant differences between protein forms to advance diagnostics and therapeutics development.
Neil Kelleher, Professor of Chemistry, Weinberg College of Arts and Sciences
Laborecom Therapeutics is developing a peptide therapeutic to prevent long-term damage to the heart after a heart attack. By leveraging novel endothelial cell biology, they aim to reduce inflammatory cell accumulation, protect the heart from damage, and save patient lives.
William A. Muller, Professor of Pathology, Feinberg School of Medicine
Melanyze harnesses the power of synthetic melanin chemistry and biology to redefine skin regeneration and repair that address critical gaps in topical therapies.
Nathan Gianneschi, Professor of Chemistry, Weinberg College of Arts & Sciences
Kurt Lu, Professor of Dermatology, Feinberg School of Medicine
NylaNova delivers a one-step chemical recycling technology that converts post-industrial and post-consumer nylon waste into high-quality caprolactam. Their catalyst system enables efficient, cost-effective circularity for partners across multiple industries.
Yosi Kratish, Research Assistant Professor, Weinberg College of Arts & Sciences
Tobin Marks, Professor of Chemistry, Weinberg College of Arts & Sciences
RMD Sciences is pioneering a novel Alzheimer's disease therapy that selectively promotes the growth of specific gut flora to improve brain function.
Kazuhiro Shimomura
SNC Therapeutics is developing a rational immunotherapy platform utilizing scalable versatile synthetic nanocarriers (SNCs) for targeted drug delivery and transfection of diverse cell populations in autoimmune diseases.
Evan Scott
Third Coast is developing a cloud-based risk stratification tool for aortic diseases that uses artificial intelligence to provide hemodynamic imaging biomarkers from standard CT angiography and MR angiography images.
Michael Markl, Professor of Radiology, Feinberg School of Medicine
Bradley Allen, Professor of Radiology, Feinberg School of Medicine
Actinia is developing a new detector of materials to double the resolution of X-ray and gamma-ray imaging technologies to improve the safety, efficiency, and security of nuclear technologies used in power generation, national defense, and medical imaging.
Mercouri G. Kanatzisia, Professor of Chemistry, Weinberg College of Arts & Sciences
Aplexis is an early-stage therapeutic company focused on treating myeloproliferative neoplasms with characteristic Plek2 overexpression. Aplexis has identified novel Plek2 inhibitors and is currently optimizing the lead compounds and finalizing functional testing.
Peng Ji, Professor of Pathology, Feinberg School of Medicine
ARMA Biosciences has developed a rapid, versatile sensor platform capable of continuous monitoring for a multitude of physiological markers. For example, indicators of heart failure progression, including NT-proBNP, CRP, and Cardiac Troponin I.
Shana Kelley, Professor of Chemistry, Weinberg College of Arts & Sciences
Flashpoint is developing nanotherapeutic candidates that can co-deliver precise RNA, DNA and peptide payloads to the right cells at the right time to treat various types of cancer including pancreatic, head/neck, cervical, and glioblastoma.
Chad Mirkin, Professor of Chemistry, Weinberg College of Arts & Sciences
GO-Eco (formally Chang Robotics) is developing water-based barrier coatings for food packaging based on graphene oxide technology.
SonBinh T. Nguyen, Professor of Chemistry, Weinberg College of Arts & Sciences
Coral Innovations uses a multi-functional nanostructured coating platform to efficiently remove targeted water pollutants (oil, phosphates, heavy metals) in applications across a wide range of industries.
Vinayak Dravid, Professor of Materials Science and Engineering, McCormick School of Engineering
HemoRhythmics provides smart solutions for implantable medical devices and human health sensors.
John Rogers, Professor of Materials Science and Engineering, McCormick School of Engineering
Opera Bioscience is developing a novel next-generation bacterial protein expression system capable of manufacturing high quality proteins without the costly and time-consuming purification steps.
Danielle Tullman-Ercek, Professor of Biological and Chemical Engineering, McCormick School of Engineering
PreDx develops bio-responsive MRI contrast agents that make senescent cells visible in real time, enabling non-invasive insight into disease progression and treatment response. Their technology brings molecular-level precision to evaluating senolytic therapies, gene delivery, and other biological changes.
Thomas Meade, Professor of Chemistry, Weinberg College of Arts & Sciences
Rhaeos addresses a critical unmet need in the care of patients with hydrocephalus. Arising from a collaboration between materials scientists and neurological surgeons at Northwestern University, they have developed a noninvasive thermal sensor for use in the monitoring of ventricular shunt function.
John Rogers, Professor of Materials Science and Engineering, McCormick School of Engineering
Skyway Biosciences is commercializing an innovative blood collection technology that enables accurate and reliable testing from a single drop of blood while improving sample collection and preservation during transport.
Thomas McDade, Carlos Montezuma Professor of Anthropology, Weinberg College of Arts & Sciences
William Funk, Associate Professor of Preventative Medicine, Feinberg School of Medicine
Stemloop developed cell-free technology to decentralize and democratize the testing of health threats, such as lead in drinking water and pathogens in the environment.
Julius Lucks, Associate Chair of Chemical and Biological Engineering, McCormick School of Engineering
Michael Jewett
Syenex uses synthetic biology to develop improved gene delivery technologies.
Joshua Leonard, Professor of Chemical and Biological Engineering, McCormick School of Engineering
Temprian Oncology develops highly selective supercarriers for the treatment of cutaneous and ocular melanoma.
Caroline LePoole, Professor of Dermatology, Feinberg School of Medicine
Sonbinh Nguyen, Professor of Chemistry, Weinberg College of Arts & Sciences
Volexion is developing advanced cathode materials for lithium ion batteries that overcome key limitations to conventional technology, primarily enhanced battery performance at low temperatures and rapid charging and discharging. Their cathode material provides high energy efficiency, improves cycling stability, and utilizes safer materials.
Mark C. Hersam, Professor of Materials Science and Engineering, McCormick School of Engineering